Patent ID: 6517864
Filing Date: 2003-02-11
Classification: A61K,A61P

Abstract:
Device for transdermal administration, comprisingat least one compound having a therapeutic effect against an overactive bladder in a living body which is selected from the group consisting of (R)-tolterodine or the racemate thereof, salts thereof, prodrugs thereof, and metabolites thereof, and a transdermal administration device selected from the group consisting of a reservoir, a matrix, a drug-in-adhesive, a multi-laminate, a polymer-system with no foils, a iontophoretic device, and combinations thereof, an electroporation, an electroosmosis, an electroincorporation and a jet injection device which contains said compound and which has an hourly flux rate of said at least one compound from about 0.1 &mgr;g/h/cm2 to about 100 &mgr;g/h/cm2.